The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

As cannabis becomes more widely accepted, it’s important to stay informed and consume responsibly. Whether you’re seeking relaxation, therapeutic relief, or recreational enjoyment, taking the time to ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...

Innovative synthetic biology techniques are revolutionizing microbiota-based therapies, enhancing microbial functions for ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

A study led by Dr. Peter Canoll's lab, in collaboration with researchers at Columbia University Irving Medical Center, ...

Discover the potential of lycopene in alleviating depression. Learn how the compound found in tomatoes improves brain cell ...

A few companies are in clinicals with novel approaches to heal an initial brain injury or minimize secondary damage. Slow progress may be more related to investors’ misperceptions of the topic than ...

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...